echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Neurol: In-hospital stroke patients infusion treatment rate and functional prognostic study.

    JAMA Neurol: In-hospital stroke patients infusion treatment rate and functional prognostic study.

    • Last Update: 2020-10-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Statistics show that a significant proportion of acute ischemic stroke occurs during hospitalization, and researchers recently assessed the time-change trend of intravenous and intravascular refill therapy for hospital stroke.
    this retrospective queue study analyzed data collected from January 2008 to September 2018 in the GetWithGuidelines-Stroke National Database on patients receiving stroke treatment, who became ill in or outside the hospital.
    endpoints of the study were the correlation between time-varying trends, quality, functional results and key patient characteristics, co-disease and treatment in infusion therapy.
    Of the 67,493 hospitalized stroke patients, patients receiving intravascular therapy (average age 69 years, 49.8 percent of women) had a higher rate of vascular risk factors (standardized average difference of 10 percent), but no significant difference in age or sex compared to patients who received only venous thrombosis (average age 72 years, 53.2 percent of women).
    10481 (15.5%) received intravenous thrombosis and 2494 (3.7%) received intravascular treatment.
    compared to 2008, the proportion of hospitalized stroke patients increased in 2018 (3.5% vs. 2.7%), while the proportion of inpatient stroke patients using venous thrombosis (19.1% vs 9.1%) and intravascular therapy (6.4% vs 2.5%) increased significantly, with a significant increase in 2015.
    compared to out-of-hospital stroke patients treated with venous thrombosis, inpatients took longer to go from stroke recognition to a mid-level (IQR) of 33 vs 16 minutes) and thrombosis (81 vs 60 minutes).
    After adjustment, compared with patients with out-of-hospital morbidity and receiving venous thrombosis treatment, patients with inpatient stroke who received venous thrombosis treatment had an increased risk of not being able to walk independently, die or receive hospice care (adjusted ratio of 1.39), and patients with intravascular treatment had a poor prognosis.
    study found that the incidence of stroke in hospital showed an upward trend, compared with out-of-hospital stroke attacks, patients with in-hospital re-perfusion delay is longer, the functional prognostication is poor.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.